BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22669466)

  • 1. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.
    Revilla-I-Domingo R; Bilic I; Vilagos B; Tagoh H; Ebert A; Tamir IM; Smeenk L; Trupke J; Sommer A; Jaritz M; Busslinger M
    EMBO J; 2012 Jun; 31(14):3130-46. PubMed ID: 22669466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pax5: a master regulator of B cell development and leukemogenesis.
    Medvedovic J; Ebert A; Tagoh H; Busslinger M
    Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis.
    Decker T; Pasca di Magliano M; McManus S; Sun Q; Bonifer C; Tagoh H; Busslinger M
    Immunity; 2009 Apr; 30(4):508-20. PubMed ID: 19345119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
    Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
    Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired box gene 5 isoforms A and B have different functions in transcriptional regulation of B cell development-related genes in immature B cells.
    Kikuchi H; Nakayama M; Kuribayashi F; Mimuro H; Imajoh-Ohmi S; Nishitoh H; Takami Y; Nakayama T
    Microbiol Immunol; 2015 Jul; 59(7):426-31. PubMed ID: 26094714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pax5: the guardian of B cell identity and function.
    Cobaleda C; Schebesta A; Delogu A; Busslinger M
    Nat Immunol; 2007 May; 8(5):463-70. PubMed ID: 17440452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation.
    Carotta S; Holmes ML; Pridans C; Nutt SL
    Cell Cycle; 2006 Nov; 5(21):2452-6. PubMed ID: 17102626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.
    Simmons S; Knoll M; Drewell C; Wolf I; Mollenkopf HJ; Bouquet C; Melchers F
    Blood; 2012 Nov; 120(18):3688-98. PubMed ID: 22927250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function.
    Fuxa M; Busslinger M
    J Immunol; 2007 Jun; 178(12):8222-8. PubMed ID: 17600970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of the Pax5 C-terminal domain in controlling B cell commitment and development.
    Gruenbacher S; Jaritz M; Hill L; Schäfer M; Busslinger M
    J Exp Med; 2023 Dec; 220(12):. PubMed ID: 37725138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function.
    Fuxa M; Busslinger M
    J Immunol; 2007 Mar; 178(5):3031-7. PubMed ID: 17312149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis.
    Nutt SL; Eberhard D; Horcher M; Rolink AG; Busslinger M
    Int Rev Immunol; 2001 Feb; 20(1):65-82. PubMed ID: 11342298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
    Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
    J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distal V(H) gene cluster of the Igh locus contains distinct regulatory elements with Pax5 transcription factor-dependent activity in pro-B cells.
    Ebert A; McManus S; Tagoh H; Medvedovic J; Salvagiotto G; Novatchkova M; Tamir I; Sommer A; Jaritz M; Busslinger M
    Immunity; 2011 Feb; 34(2):175-87. PubMed ID: 21349430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of the B-cell gene expression programme by Pax5.
    Holmes ML; Pridans C; Nutt SL
    Immunol Cell Biol; 2008 Jan; 86(1):47-53. PubMed ID: 17998914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing of the trout Pax5 gene and identification of novel B cell populations using Pax5 signatures.
    MacMurray E; Barr M; Bruce A; Epp L; Zwollo P
    Dev Comp Immunol; 2013 Oct; 41(2):270-81. PubMed ID: 23796789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early B-cell factor 1 regulates the expansion of B-cell progenitors in a dose-dependent manner.
    Åhsberg J; Ungerbäck J; Strid T; Welinder E; Stjernberg J; Larsson M; Qian H; Sigvardsson M
    J Biol Chem; 2013 Nov; 288(46):33449-61. PubMed ID: 24078629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-dependent role for EBF1 in repressing non-B-cell-specific genes.
    Lukin K; Fields S; Guerrettaz L; Straign D; Rodriguez V; Zandi S; Månsson R; Cambier JC; Sigvardsson M; Hagman J
    Eur J Immunol; 2011 Jun; 41(6):1787-93. PubMed ID: 21469119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells.
    McManus S; Ebert A; Salvagiotto G; Medvedovic J; Sun Q; Tamir I; Jaritz M; Tagoh H; Busslinger M
    EMBO J; 2011 May; 30(12):2388-404. PubMed ID: 21552207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene.
    Sekine R; Kitamura T; Tsuji T; Tojo A
    Int J Hematol; 2008 May; 87(4):351-362. PubMed ID: 18415655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.